Information Provided By:
Fly News Breaks for April 5, 2016
CNC
Apr 5, 2016 | 07:35 EDT
California's regulatory approval of Centene's acquisition of Health Net removes a key overhang, Jefferies analyst David Windley tells investors in a research note. The conditions of approval seem manageable and investors can now expect "robust" earnings growth from Centene, the analyst contends. He sees earnings growth of 35% and 26% over the next two years for the company. Windley says Centene remains a top pick with a Buy rating and $80 price target.
News For CNC From the Last 2 Days
There are no results for your query CNC